Ulrich Engelhardt

Title: Ulrich Engelhardt: Innovator in Crystallization Inhibition

Introduction

Ulrich Engelhardt, an inventive mind hailing from Leverkusen, Germany, has made significant contributions to the field of chemical innovations. With a portfolio that boasts three patents, Engelhardt's work primarily focuses on the development of crystallization inhibitors, which are essential for various industrial applications.

Latest Patents

Engelhardt's latest patents exhibit his commitment to innovation. One of his notable inventions is titled "N-alkyl-lactams as crystallization inhibitors." This patent outlines a method for improving the spraying process of an aqueous liquor that includes compounds like 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-yl-methyl)-pentan-3-ol. The invention emphasizes the incorporation of an N-alkyl-lactam, where the alkyl chain consists of 8 to 18 carbon atoms, enhancing crystallization control.

Another significant patent by Engelhardt is "Alkylcarboxylic acid dimethylamides as crystallization inhibitors." This invention prevents the crystallization of active materials during the spraying of aqueous solutions by integrating alkylcarboxylic acid dimethylamide. In this case, the alkyl group has 5 to 19 carbon atoms, demonstrating Engelhardt's focus on improving crystallization processes through innovative chemical solutions.

Career Highlights

Engelhardt is currently associated with Bayer Aktiengesellschaft, a leading global company in the pharmaceutical and life sciences sector. His research and development efforts have played a crucial role in advancing Bayer's capabilities in chemical formulations. Engelhardt's dedication to innovation is reflected in the practical applications of his patents, aimed at enhancing product performance in various industries.

Collaborations

Collaboration has been a cornerstone of Engelhardt's career. He has worked alongside esteemed colleagues such as Heinz-Otto Horstmann and Karl Reizlein, pooling their expertise to drive forward the boundaries of invention. These partnerships have not only fostered a creative environment but have also led to the successful development of advanced crystallization inhibitors.

Conclusion

Ulrich Engelhardt stands out as a prolific inventor whose work in crystallization inhibition is making waves in the chemical industry. With his latest patents, he continues to push the envelope of innovation at Bayer Aktiengesellschaft. Engelhardt's collaborations and commitment to research exemplify the spirit of invention, paving the way for future advancements in chemical formulations.